MedTrace Logo

Vitamin D Supplementation to Patients With Type 2 Diabetes

NCT00400491 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-05-23

No results posted yet for this study

Summary

The purpose of the study is to evaluate if supplementation with vitamin D in a dose of 40.000 IU per week will result in improved metabolic control in patients with type 2 diabetes.

Conditions

Interventions

DRUG

Cholecalciferol (vitamin D)

Cholecalciferol capsule 20.000 IU twice per week for 6 months

DRUG

Placebo

Placebo capsule twice a week, identical to the cholecalciferol capsules

Sponsors & Collaborators

  • University of Tromso

    lead OTHER

Principal Investigators

  • Rolf Jorde, Professor · University of Tromsø, Tromsø

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-08-31
Completion
2007-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00400491 on ClinicalTrials.gov